...
首页> 外文期刊>Teratogenesis, carcinogenesis, and mutagenesis >Assessment of microsatellite instability in bladder and thyroid malignancies.
【24h】

Assessment of microsatellite instability in bladder and thyroid malignancies.

机译:评估膀胱和甲状腺恶性肿瘤中的微卫星不稳定性。

获取原文
获取原文并翻译 | 示例

摘要

Microsatellite instability (MSI) is an indicator of a defective DNA mismatch repair system (MMR) that results from somatic mutations. The present work has been planned to investigate MSI and its clinical significance in human urinary bladder and thyroid cancers in Indian patients. Tumor tissues of histologically confirmed cases of urinary bladder and thyroid cancers, respectively, were obtained. Clinical data on tumor stage and histopathological grades were recorded. Corresponding matched peripheral blood was taken as a control. Genomic DNA was isolated from the tumor tissues and blood using a standard phenol-chloroform extraction method. Polymerase chain reaction was done to amplify mononucleotide microsatellite markers, BAT-26, BAT-40, TGFbetaRII, IGFIIR, hMSH3, and Bax by using specific primer sequences. For analysis of allelic patterns, the PCR products were run on 8% denaturing Polyacrylamide gel and sizing was done using a pUC18 sequencing ladder. The instability with BAT-26 and BAT-40 was found to be 20% and 45% in urinary bladder and 33% and 19% in thyroid cancers, respectively. However, no instability was observed with the other four-mononucleotide markers in either of the cancers studied. Eighty-three percent of the unstable urinary bladder cancers were found to have a high grade in a superficial group, whereas only 27% MSI+ve were muscle invasive cancers. Forty percent of unstable thyroid lesions were found to be at high risk of developing metastasis. Association of BAT-26 and BAT-40 instabilities with high grade tumors as well as risk tumors may help in choosing a more definite therapy at the outset. Teratogenesis Carcinog. Mutagen. Suppl. 1:255-265, 2003. Copyright 2003 Wiley-Liss, Inc.
机译:微卫星不稳定性(MSI)是由体细胞突变导致的DNA错配修复系统(MMR)缺陷的指示。已经计划了这项工作,以调查MSI及其在印度患者的人膀胱癌和甲状腺癌中的临床意义。获得了经组织学证实的膀胱癌和甲状腺癌病例的肿瘤组织。记录有关肿瘤分期和组织病理学分级的临床数据。相应的匹配外周血作为对照。使用标准的苯酚-氯仿提取方法从肿瘤组织和血液中分离基因组DNA。通过使用特异性引物序列进行聚合酶链反应以扩增单核苷酸微卫星标记BAT-26,BAT-40,TGFbetaRII,IGFIIR,hMSH3和Bax。为了分析等位基因模式,将PCR产物在8%变性聚丙烯酰胺凝胶上电泳,并使用pUC18测序阶梯进行上浆。发现BAT-26和BAT-40的不稳定性在膀胱中分别为20%和45%,在甲状腺癌中分别为33%和19%。然而,在所研究的任何一种癌症中,其他四单核苷酸标记均未观察到不稳定。发现浅表组中有83%的不稳定型膀胱癌具有较高的等级,而MSI + ve仅27%是肌肉浸润性癌。发现40%的不稳定甲状腺病变处于发生转移的高风险中。 BAT-26和BAT-40不稳定性与高级别肿瘤以及高风险肿瘤的关联可能有助于在一开始就选择更明确的治疗方法。致癌作用。诱变剂。补充1:255-265,2003年。版权所有2003 Wiley-Liss,Inc.。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号